Factor | Categories | Disease-free patients | Relapsed patients | P value |
N | 92 | 16 | ||
Age, mean (SD) | 43.8 (13.4) | 49.3 (15.4) | 0.14 | |
Histologic sub-type, n (%) | Squamous cell carcinoma | 64 (70%) | 13 (81%) | 0.84 |
Adenocarcinoma | 24 (26%) | 3 (19%) | ||
Adenosquamous carcinoma | 4 (4%) | 0 (0%) | ||
Stage of disease, n (%) | IA1 with LVSI −1A2 | 9 (10%) | 0 (0%) | 0.62 |
IB1 | 83 (90%) | 16 (100%) | ||
Positive lymph nodes, n (%) | No | 78 (85%) | 13 (81%) | 0.71 |
Yes | 14 (15%) | 3 (19%) | ||
Parametrial involvement, n (%) | No | 77 (84%) | 13 (81%) | 0.81 |
Yes | 15 (16%) | 3 (19%) | ||
Lymphovascular invasion | No | 61 (66%) | 11 (69%) | 0.54 |
Yes | 31 (34%) | 5 (31%) | ||
Tumor size | ≤2 cm | 51 (56%) | 7 (45%) | 0.61 |
>2 cm | 41 (44%) | 9 (55%) |
LVSI, lymphovascular space invasion.